Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib

Gefitinib resistance in triple negative breast cancer (TNBC) is a growing important concern. Glutathione peroxidase 4 (GPX4) is a main regulator of ferroptosis, which is pivotal for TNBC cell growth. We investigated GPX4-mediated ferroptosis in gefitinib sensitivity in TNBC. Gefitinib resistant TNBC...

Full description

Bibliographic Details
Main Authors: Xiang Song, Xinzhao Wang, Zhaoyun Liu, Zhiyong Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.597434/full
_version_ 1818844608882278400
author Xiang Song
Xinzhao Wang
Zhaoyun Liu
Zhiyong Yu
author_facet Xiang Song
Xinzhao Wang
Zhaoyun Liu
Zhiyong Yu
author_sort Xiang Song
collection DOAJ
description Gefitinib resistance in triple negative breast cancer (TNBC) is a growing important concern. Glutathione peroxidase 4 (GPX4) is a main regulator of ferroptosis, which is pivotal for TNBC cell growth. We investigated GPX4-mediated ferroptosis in gefitinib sensitivity in TNBC. Gefitinib resistant TNBC cells MDA-MB-231/Gef and HS578T/Gef were constructed and treated with lentivirus sh-GPX4 and ferroptosis inhibitor ferrostatin-1. GPX4 expression, cell viability and apoptosis were detected. Malondialdehyde (MDA), glutathione (GSH), reactive oxygen species (ROS) levels were evaluated. The levels of ferroptosis-related proteins were detected. Subcutaneous tumor model was established in nude mice, and gefitinib was intraperitoneally injected to evaluate tumor growth, apoptosis, and Ki-67 expression. GPX4 was increased in gefitinib-resistant cells. After silencing GPX4, the inhibition rate of cell viability was increased, the limitation of colony formation ability was reduced, apoptosis rate was increased, and the sensitivity of cells to gefitinib was improved. After silencing GPX4, MDA and ROS production were increased, while GSH was decreased. Silencing GPX4 promoted ferroptosis. Inhibition of GPX4 promoted gefitinib sensitivity by promoting cell ferroptosis. In vivo experiments also revealed that inhibition of GPX4 enhanced the anticancer effect of gefitinib through promoting ferroptosis. Overall, inhibition of GPX4 stimulated ferroptosis and enhanced TNBC cell sensitivity to gefitinib.
first_indexed 2024-12-19T05:16:29Z
format Article
id doaj.art-e0251805d8ac4c0da9bac40c0d49f973
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T05:16:29Z
publishDate 2020-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-e0251805d8ac4c0da9bac40c0d49f9732022-12-21T20:34:39ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-12-011010.3389/fonc.2020.597434597434Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to GefitinibXiang SongXinzhao WangZhaoyun LiuZhiyong YuGefitinib resistance in triple negative breast cancer (TNBC) is a growing important concern. Glutathione peroxidase 4 (GPX4) is a main regulator of ferroptosis, which is pivotal for TNBC cell growth. We investigated GPX4-mediated ferroptosis in gefitinib sensitivity in TNBC. Gefitinib resistant TNBC cells MDA-MB-231/Gef and HS578T/Gef were constructed and treated with lentivirus sh-GPX4 and ferroptosis inhibitor ferrostatin-1. GPX4 expression, cell viability and apoptosis were detected. Malondialdehyde (MDA), glutathione (GSH), reactive oxygen species (ROS) levels were evaluated. The levels of ferroptosis-related proteins were detected. Subcutaneous tumor model was established in nude mice, and gefitinib was intraperitoneally injected to evaluate tumor growth, apoptosis, and Ki-67 expression. GPX4 was increased in gefitinib-resistant cells. After silencing GPX4, the inhibition rate of cell viability was increased, the limitation of colony formation ability was reduced, apoptosis rate was increased, and the sensitivity of cells to gefitinib was improved. After silencing GPX4, MDA and ROS production were increased, while GSH was decreased. Silencing GPX4 promoted ferroptosis. Inhibition of GPX4 promoted gefitinib sensitivity by promoting cell ferroptosis. In vivo experiments also revealed that inhibition of GPX4 enhanced the anticancer effect of gefitinib through promoting ferroptosis. Overall, inhibition of GPX4 stimulated ferroptosis and enhanced TNBC cell sensitivity to gefitinib.https://www.frontiersin.org/articles/10.3389/fonc.2020.597434/fulltriple negative breast cancergefitinibGPX4ferroptosissensitivity
spellingShingle Xiang Song
Xinzhao Wang
Zhaoyun Liu
Zhiyong Yu
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
Frontiers in Oncology
triple negative breast cancer
gefitinib
GPX4
ferroptosis
sensitivity
title Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
title_full Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
title_fullStr Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
title_full_unstemmed Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
title_short Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
title_sort role of gpx4 mediated ferroptosis in the sensitivity of triple negative breast cancer cells to gefitinib
topic triple negative breast cancer
gefitinib
GPX4
ferroptosis
sensitivity
url https://www.frontiersin.org/articles/10.3389/fonc.2020.597434/full
work_keys_str_mv AT xiangsong roleofgpx4mediatedferroptosisinthesensitivityoftriplenegativebreastcancercellstogefitinib
AT xinzhaowang roleofgpx4mediatedferroptosisinthesensitivityoftriplenegativebreastcancercellstogefitinib
AT zhaoyunliu roleofgpx4mediatedferroptosisinthesensitivityoftriplenegativebreastcancercellstogefitinib
AT zhiyongyu roleofgpx4mediatedferroptosisinthesensitivityoftriplenegativebreastcancercellstogefitinib